ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Cell Carcinoma
Renal Insufficiency
Membranous Glomerulonephritis

Kidney Disease trials near San Francisco, CA, USA:

Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease (TOP-CKD)

Kidney disease is a global health problem, affecting more than 10% of the world's population and more than half of adults over 70 y ...

Enrolling
Chronic Kidney Disease
Drug: matching placebo
Drug: Pirfenidone

Phase 2

Veterans Medical Research Foundation

San Francisco, California, United States and 1 other location

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...

Enrolling
Kidney Failure, Chronic
Diabetic Nephropathies
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Stanford, California, United States and 17 other locations

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

Phase 2, Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

San Francisco, California, United States and 330 other locations

The purpose of this study is to determine whether vonsetamig will safely decrease anti-HLA antibodies to allow for kidney transplantation.Vo...

Enrolling
Chronic Kidney Disease (CKD)
Drug: Vonsetamig

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

San Francisco, California, United States and 9 other locations

to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...

Active, not recruiting
Chronic Kidney Disease With High Proteinuria
Drug: Dapagliflozin
Drug: Zibotentan/Dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

San Carlos, California, United States and 295 other locations

This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...

Begins enrollment this month
Chronic Kidney Disease
Drug: Placebo
Drug: Empagliflozin

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

San Francisco, California, United States and 100 other locations

The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Semaglutide

Phase 2

Novo Nordisk
Novo Nordisk

San Ramon, California, United States and 133 other locations

and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...

Enrolling
Chronic Kidney Disease and Hypertension
Drug: Baxdrostat/dapagliflozin
Drug: Placebo/dapagliflozin

Phase 3

AstraZeneca
AstraZeneca

San Francisco, California, United States and 716 other locations

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...

Active, not recruiting
Chronic Kidney Disease
Cardiac Disease
Drug: Placebo
Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals
Alexion Pharmaceuticals

San Francisco, California, United States and 166 other locations

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...

Enrolling
Chronic Kidney Disease
Proteinuria
Drug: Finerenone (Kerendia, BAY94-8862)

Phase 3

Bayer
Bayer

Palo Alto, California, United States and 170 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems